Blueprint Medicines Ownership | Who Owns Blueprint Medicines?

Overview Forecast RevenueFinancials Chart Transcripts

Blueprint Medicines Ownership Summary

Blueprint Medicines is owned by 106.14% institutional investors, 1.27% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.84% of BPMC shares. Vanguard Health Care Inv is the top mutual fund, with 3.29% of its assets in Blueprint Medicines shares.

BPMC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Blueprint Medicines	106.14%	1.27%	-7.40%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	6.87M	10.84%	$599.14M
Vanguard group	6.77M	10.69%	$590.91M
Blackrock	6.65M	10.58%	$716.45M
Price t rowe associates inc /md/	5.68M	8.96%	$495.33M
Wellington management group llp	4.28M	6.75%	$373.42M
State street	2.50M	3.94%	$218.07M
Fmr	2.25M	3.55%	$196.04M
William blair investment management	1.94M	3.07%	$169.62M
Geode capital management	1.49M	2.35%	$130.00M
Macquarie group	1.26M	1.99%	$109.81M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aquilo capital management	129.60K	17.04%	$11.30M
Ally bridge group (ny)	55.89K	4.18%	$4.87M
Orion investment	108.67K	3.78%	$9.48M
Rock springs capital management lp	1.10M	3.64%	$95.67M
Dafna capital management	149.76K	3.32%	$13.06M
Exome asset management	31.80K	2.08%	$2.77M
Integral health asset management	275.00K	2.04%	$23.99M
Logos global management lp	200.00K	2.04%	$17.44M
Ikarian capital	169.37K	2.01%	$14.77M
Casdin capital	326.38K	1.89%	$28.47M

Top Buyers

Holder	Shares	% Assets	Change
Avoro capital advisors	1.19M	1.46%	1.19M
Norges bank	711.16K	0.01%	711.16K
Eventide asset management	862.28K	1.37%	513.58K
1832 asset management	502.65K	0.04%	502.40K
Jennison associates	360.21K	0.02%	360.21K

Top Sellers

Holder	Shares	% Assets	Change
Fmr	2.25M	0.01%	-2.27M
Lord, abbett	335.04K	0.09%	-843.15K
Morgan stanley	421.26K	0.00%	-637.43K
Man group	103.92K	0.02%	-414.70K
Driehaus capital management	-	-	-358.25K

New Positions

Holder	Shares	% Assets	Change	Value
Avoro capital advisors	1.19M	1.46%	1.19M	$103.36M
Norges bank	711.16K	0.01%	711.16K	$62.03M
Jennison associates	360.21K	0.02%	360.21K	$31.42M
Raymond james financial	241.97K	0.01%	241.97K	$21.10M
Logos global management lp	200.00K	2.04%	200.00K	$17.44M

Sold Out

Holder	Change
Financial gravity asset management	-4.00
Rakuten securities	-5.00
Innealta capital	-6.00
Td waterhouse canada	-21.00
Hollencrest capital management	-30.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	362	5.23%	67,270,926	3.92%	106	1.02%	202	2.02%	102	21.43%
Sep 30, 2024	339	3.04%	64,638,237	-2.28%	101	0.92%	196	17.37%	83	-17.82%
Jun 30, 2024	329	7.17%	66,148,228	1.60%	105	0.94%	167	8.44%	101	9.78%
Mar 31, 2024	307	9.64%	65,103,888	1.92%	105	0.95%	154	22.22%	92	-3.16%
Dec 31, 2023	280	19.66%	63,876,902	-0.34%	105	0.95%	126	5.88%	95	63.79%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	2.09M	3.29%	285.60K
US Small-Cap Growth II Equity Comp	2.05M	3.23%	-12.67K
T. Rowe Price New Horizons	2.02M	3.17%	-
Vanguard US Total Market Shares ETF	2.00M	3.13%	1.81K
Vanguard Total Stock Mkt Idx Inv	1.99M	3.12%	1.25K
iShares Russell 2000 ETF	1.67M	2.62%	-14.46K
Vanguard Small Cap Index	1.62M	2.54%	1.32K
T. Rowe Price Health Sciences	1.62M	2.53%	-151.10K
SPDR® S&P Biotech ETF	1.22M	1.90%	-13.04K
Vanguard Institutional Extnd Mkt Idx Tr	968.36K	1.52%	1.34K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 01, 2025	Haviland Kate	CHIEF EXECUTIVE OFFICER	Sell	$8.86K
Apr 01, 2025	Haviland Kate	CHIEF EXECUTIVE OFFICER	Sell	$51.51K
Apr 01, 2025	Haviland Kate	CHIEF EXECUTIVE OFFICER	Sell	$104.81K
Apr 01, 2025	Haviland Kate	CHIEF EXECUTIVE OFFICER	Sell	$51.28K
Mar 24, 2025	Rossi Christina	CHIEF OPERATING OFFICER	Sell	$216.08K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	4
2025 Q1	-	32
2024 Q4	-	18
2024 Q3	-	6
2024 Q2	-	21

BPMC Ownership FAQ

Who Owns Blueprint Medicines?

Blueprint Medicines shareholders are primarily institutional investors at 106.14%, followed by 1.27% insiders and -7.41% retail investors. The average institutional ownership in Blueprint Medicines's industry, Biotech Stocks , is 68.48%, which Blueprint Medicines exceeds.

Who owns the most shares of Blueprint Medicines?

Blueprint Medicines’s largest shareholders are Blackrock funding, inc. /de (6.87M shares, 10.84%), Vanguard group (6.77M shares, 10.69%), and Blackrock (6.65M shares, 10.58%). Together, they hold 32.10% of Blueprint Medicines’s total shares outstanding.

Does Blackrock own Blueprint Medicines?

Yes, BlackRock owns 10.58% of Blueprint Medicines, totaling 6.65M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 716.45M$. In the last quarter, BlackRock increased its holdings by 199.84K shares, a 3.10% change.

Who is Blueprint Medicines’s biggest shareholder by percentage of total assets invested?

Aquilo capital management is Blueprint Medicines’s biggest shareholder by percentage of total assets invested, with 17.04% of its assets in 129.6K Blueprint Medicines shares, valued at 11.3M$.

Who is the top mutual fund holder of Blueprint Medicines shares?

Vanguard Health Care Inv is the top mutual fund holder of Blueprint Medicines shares, with 3.29% of its total shares outstanding invested in 2.09M Blueprint Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools